18 Stocks Moving in Friday’s Pre-Market Session
Gainers
Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-XR decreased proliferation in tumors with high PR+ at baseline in early breast cancer.